Stay ahead in the evolving pharmaceutical industry with SGA’s comprehensive pharma analytics services. As a leading pharma analytics solutions company, we help organizations harness data-driven strategies, accelerate research, enhance patient care, and ensure regulatory compliance through advanced analytics and AI-powered solutions.
Aggregate and process massive, diverse datasets from clinical, operational, and patient sources for comprehensive analytics that handle the 30% of global data volume generated by healthcare.
Drive predictive modeling, automate diagnostics, and enable personalized medicine with advanced algorithms that analyze genomics, proteomics, and clinical data.
Centralize data storage, ensure scalability, and provide secure, real-time access to analytics with HIPAA-compliant infrastructure.
Deliver intuitive, actionable insights to clinicians, researchers, and executives for faster, better decisions with customizable reporting capabilities.
Capture real-world patient data for continuous monitoring and proactive care through connected medical devices and smart sensors.
Seamlessly connect analytics with Electronic Health Records (EHRs), Electronic Medical Records (EMRs), Laboratory Information Management Systems (LIMS), and other healthcare systems for unified data visibility while maintaining HIPAA compliance.
Aggregate and process massive, diverse datasets from clinical, operational, and patient sources for comprehensive analytics that handle the 30% of global data volume generated by healthcare.
Drive predictive modeling, automate diagnostics, and enable personalized medicine with advanced algorithms that analyze genomics, proteomics, and clinical data.
Centralize data storage, ensure scalability, and provide secure, real-time access to analytics with HIPAA-compliant infrastructure.
Deliver intuitive, actionable insights to clinicians, researchers, and executives for faster, better decisions with customizable reporting capabilities.
Capture real-world patient data for continuous monitoring and proactive care through connected medical devices and smart sensors.
Seamlessly connect analytics with Electronic Health Records (EHRs), Electronic Medical Records (EMRs), Laboratory Information Management Systems (LIMS), and other healthcare systems for unified data visibility while maintaining HIPAA compliance.
SGA delivers end-to-end analytics services, from data integration and dashboarding to advanced AI insights and continuous optimization. Our proven methodologies, deep domain expertise, and regulatory know-how ensure measurable outcomes for pharma industry worldwide. With the pharmaceutical analytics market projected to reach $15 billion by 2034 at 8.5% CAGR, we help clients stay ahead of industry transformation.
Proven experience in pharma analytics with 18+ years of industry expertise. Deep understanding of regulatory and compliance requirements including HIPAA, GDPR, and FDA guidelines. Strong data security and privacy protocols with enterprise-grade encryption. Scalable and interoperable technology stack supporting cloud, on-premise, and hybrid deployments.
BLOG
Health Technology Assessment (HTA) plays a vital role in determining patient access and reimbursement across European markets. With the HTA Regulation (EU 2021/2282) set to take effect in 2025, pharmaceutical companies must align their market access strategies accordingly. Agencies like France’s HAS, Germany’s GBA, and Scotland’s SMC assess the clinical and cost-effectiveness of new therapies, shaping national reimbursement decisions. Navigating this landscape requires submitting robust clinical and economic evidence through the HTA IT platform.
BLOG
As digital innovation reshapes industries globally, Japan is uniquely positioned to leverage artificial intelligence (AI) and big data within its life sciences sector. With a rapidly aging population, advanced technological infrastructure, and government initiatives promoting digital integration, Japan is primed to redefine healthcare. AI and big data are not only
Clinical trial analytics, drug discovery analytics, patient outcome analytics, regulatory compliance analytics, real-world evidence analytics, operational efficiency analytics, and medical imaging analytics that leverage AI and ML for predictive insights.
SGA integrates diverse data sources including EHRs, clinical systems, and IoT devices, builds custom AI models for predictive analytics, and provides real-time, actionable insights – supported by ongoing optimization and deep regulatory expertise across FDA, EMA, and global compliance frameworks.
They accelerate innovation, improve patient care quality, optimize resource utilization, ensure regulatory compliance, reduce operational costs by 10-30%, and drive better clinical and commercial outcomes through data-driven decision- making.
Pharma analytics focus on clinical, regulatory, and patient data unique to these sectors, . By leveraging advanced AI and big data, they deliver real-time, actionable insights that support drug discovery, patient outcomes, and compliance requirements. In contrast, traditional analytics typically address general business data from standard enterprise systems.
Implementation costs typically range from $100,000 to $1,250,000 depending on data complexity, integration requirements, and deployment scale. With the global pharmaceutical analytics market valued at $6.5 billion in 2024 and projected return on investment (ROI) up to 350%, contact us for a tailored quote based on your specific requirements.
Clinical trial analytics, drug discovery analytics, patient outcome analytics, regulatory compliance analytics, real-world evidence analytics, operational efficiency analytics, and medical imaging analytics that leverage AI and ML for predictive insights.
SGA integrates diverse data sources including EHRs, clinical systems, and IoT devices, builds custom AI models for predictive analytics, and provides real-time, actionable insights – supported by ongoing optimization and deep regulatory expertise across FDA, EMA, and global compliance frameworks.
They accelerate innovation, improve patient care quality, optimize resource utilization, ensure regulatory compliance, reduce operational costs by 10-30%, and drive better clinical and commercial outcomes through data-driven decision- making.
Pharma analytics focus on clinical, regulatory, and patient data unique to these sectors, . By leveraging advanced AI and big data, they deliver real-time, actionable insights that support drug discovery, patient outcomes, and compliance requirements. In contrast, traditional analytics typically address general business data from standard enterprise systems.
Implementation costs typically range from $100,000 to $1,250,000 depending on data complexity, integration requirements, and deployment scale. With the global pharmaceutical analytics market valued at $6.5 billion in 2024 and projected return on investment (ROI) up to 350%, contact us for a tailored quote based on your specific requirements.
Driving
AI-Led Transformation